Treatment of Hyperandrogenism in Women

    January 1996 in “ Gynecological Endocrinology
    T. Rabe, Klaus Grunwald, K. Feldmann, B. Runnebaum
    Image of study
    TLDR Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.
    In the 1996 review, T. Rabe et al. discussed the treatment of hyperandrogenism in women, emphasizing the importance of addressing this condition to prevent various health complications. They reported that 25-40% of women aged 15-25 suffer from acne vulgaris, and 15-30% of women in Germany exhibit clinically relevant symptoms of hyperandrogenism. The review found cyproterone acetate to be the most potent and well-tolerated antiandrogen, suitable for treating hyperandrogenism, especially when combined with ethinylestradiol. Other treatments such as spironolactone, flutamide, corticosteroids, and GnRH analogs were also discussed, with their efficacy, side effects, and safety considered. The authors concluded that cyproterone acetate is the preferred treatment for hyperandrogenism in women when there are no contraindications for estrogen/progestogen combinations.
    Discuss this study in the Community →

    Research cited in this study

    18 / 18 results

    Related Community Posts Join

    6 / 6 results

    Related Research

    9 / 9 results